- Release Date: 13/05/25 14:06
- Summary: NEU receives FDA minutes and re-confirms Phase 3 endpoints
- Price Sensitive: No
- Download Document 161.63KB
- Forums
- ASX - By Stock
- NEU
- Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.30%
!
$15.67

Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$15.67 |
Change
0.500(3.30%) |
Mkt cap ! $1.957B |
Open | High | Low | Value | Volume |
$15.35 | $15.92 | $15.24 | $6.718M | 429.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 2031 | $15.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.67 | 76 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7 | 15.690 |
10 | 7691 | 15.680 |
13 | 1049 | 15.670 |
10 | 1575 | 15.660 |
7 | 1142 | 15.650 |
Price($) | Vol. | No. |
---|---|---|
15.700 | 931 | 6 |
15.710 | 318 | 3 |
15.720 | 1014 | 6 |
15.730 | 1472 | 9 |
15.740 | 1380 | 7 |
Last trade - 15.14pm 22/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |